共 29 条
[13]
Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
[J].
EUROPEAN UROLOGY,
2011, 59 (05)
:856-862
[14]
Design and endpoints of clinical trials in hepatocellular carcinoma
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
2008, 100 (10)
:698-711
[15]
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[16]
2-6